Incorporating Genome-Based Technologies into Toxicology and Safety Assessments for Drug Discovery and Development

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.21, Iss.6, 2007-01, pp. : 427-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances of Fluorescent Technologies for Drug Discovery and Development

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3552-3570

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Discovery Technologies

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 5, 2004-10 ,pp. : 30-43

Adis International

Access to resources Recommend Favorite

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development

By Schlotterbeck Götz Ross Alfred Dieterle Frank Senn Hans

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 1055-1075

Future Medicine

Access to resources Recommend Favorite

Translation of New Technologies: From Basic Research to Drug Discovery and Development

Current Drug Discovery Technologies, Vol. 5, Iss. 3, 2008-09 ,pp. : 250-262

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Genetic Toxicology in Drug Discovery and Optimization

Current Drug Metabolism, Vol. 9, Iss. 9, 2008-11 ,pp. : 978-985

Bentham Science Publishers

Access to resources Recommend Favorite